Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Artificial intelligence (AI) is transforming dietary management for diabetes and obesity, offering personalized nutrition plans, real-time glucose mon.

Completing the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for ...

DANIEL ADAJI explains ways smart gadgets enhance early detection of stroke and other non-communicable diseases, the technology behind them, and their potential to revolutionise healthcare ...

Now that we're a month out from CES, these are the trends that have stuck with me. Yes, AI is on the list, of course, but so ...

Arkansas lawmakers propose the 'Healthy Moms, Healthy Babies Act' to establish presumptive Medicaid eligibility for pregnant ...

The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

The critical care patient monitoring product market has witnessed significant growth over the past few years. This surge can be attributed to advancements in healthcare technology, the increasing ...

Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your heart health at home. Here are the tools they suggest (and who they most ...

Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.